CA 19-9 as a Marker of Survival and a Predictor of Metastization in Cholangiocarcinoma

Background: Cholangiocarcinoma is the second most frequent primitive liver malignancy and is responsible for 3% of the malignant gastrointestinal neoplasms. The aims of this study were to determine the association of serum levels of CA 19-9 at diagnosis with other clinical data and serum liver funct...

ver descrição completa

Detalhes bibliográficos
Autor principal: Coelho,Rosa (author)
Outros Autores: Silva,Marco (author), Rodrigues-Pinto,Eduardo (author), Cardoso,Helder (author), Lopes,Susana (author), Pereira,Pedro (author), Vilas-Boas,Filipe (author), Santos-Antunes,João (author), Costa-Maia,José (author), Macedo,Guilherme (author)
Formato: article
Idioma:eng
Publicado em: 2017
Assuntos:
CA 19-9 antigen
Cholangiocarcinoma
Prognosis
Tumor biomarkers
Texto completo:http://scielo.pt/scielo.php?script=sci_arttext&pid=S2341-45452017000300004
País:Portugal
Oai:oai:scielo:S2341-45452017000300004

Texto Completo

http://scielo.pt/scielo.php?script=sci_arttext&pid=S2341-45452017000300004

Registros relacionados